BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations

Peron, A; D’Arco, F; Aldinger, KA; Smith-Hicks, C; Zweier, C; Gradek, GA; Bradbury, K; Accogli, A; Andersen, EF; Au, PYB; Battini, R; Beleford, D; Bird, LM; Bouman, A; Bruel, A; Busk, ØL; Campeau, PM; Capra, V; Carlston, C; Carmichael, J; Chassevent, A; Clayton-Smith, J; Bamshad, MJ; Earl, DL; Shears, D

Journal article

BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations

Abstract:: An increasing number of individuals with intellectual developmental disorder (IDD) and heterozygous variants in BCL11A are identified, yet our knowledge of manifestations and mutational spectrum is lacking. To address this, we performed detailed analysis of 42 individuals with BCL11A-related IDD (BCL11A-IDD, a.k.a. Dias-Logan syndrome) ascertained through an international collaborative network, and reviewed 35 additional previously reported patients. Analysis of 77 affected individuals identified 60 unique disease-causing variants (30 frameshift, 7 missense, 6 splice-site, 17 stop-gain) and 8 unique BCL11A microdeletions. We define the most prevalent features of BCL11A-IDD: IDD, postnatal-onset microcephaly, hypotonia, behavioral abnormalities, autism spectrum disorder, and persistence of fetal hemoglobin (HbF), and identify autonomic dysregulation as new feature. BCL11A-IDD is distinguished from 2p16 microdeletion syndrome, which has a higher incidence of congenital anomalies. Our results underscore BCL11A as an important transcription factor in human hindbrain development, identifying a previously underrecognized phenotype of a small brainstem with a reduced pons/medulla ratio. Genotype-phenotype correlation revealed an isoform-dependent trend in severity of truncating variants: those affecting all isoforms are associated with higher frequency of hypotonia, and those affecting the long (BCL11A-L) and extra-long (-XL) isoforms, sparing the short (-S), are associated with higher frequency of postnatal microcephaly. With the largest international cohort to date, this study highlights persistence of fetal hemoglobin as a consistent biomarker and hindbrain abnormalities as a common feature. It contributes significantly to our understanding of BCL11A-IDD through an extensive unbiased multi-center assessment, providing valuable insights for diagnosis, management and counselling, and into BCL11A’s role in brain development.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Peron, A., D’Arco, F., Aldinger, K. A., Smith-Hicks, C., Zweier, C., Gradek, G. A., Bradbury, K., Accogli, A., Andersen, E. F., Au, P. Y. B., Battini, R., Beleford, D., Bird, L. M., Bouman, A., Bruel, A., Busk, Ø. L., Campeau, P. M., Capra, V., Carlston, C., … Shears, D. (2024). BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations. European Journal of Human Genetics, 33(3), 312–324.

MLA Style

Peron, A., et al. “BCL11A Intellectual Developmental Disorder: Defining the Clinical Spectrum and Genotype-Phenotype Correlations.” European Journal of Human Genetics, vol. 33, no. 3, Springer Nature [academic journals on nature.com], 2024, pp. 312–24.

Chicago Style

Peron, A, F D’Arco, KA Aldinger, C Smith-Hicks, C Zweier, GA Gradek, K Bradbury, et al. 2024. “BCL11A Intellectual Developmental Disorder: Defining the Clinical Spectrum and Genotype-Phenotype Correlations.” European Journal of Human Genetics 33 (3): 312–24.
Share
Print